ConductScience.org, home

Trial · NCT05714644

Community Collaboration to Advance Racial/Ethnic Equity in CRC Screening

NCT05714644, Not applicable, Completed, Massachusetts General Hospital; results first posted 2025-12-26

3 sourcestrials-2026-11-12-0.4.0

Download JSON
Cite this record

ConductScience Library. Community Collaboration to Advance Racial/Ethnic Equity in CRC Screening. Trials, record NCT05714644. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05714644

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Community Collaboration to Advance Racial/Ethnic Equity in CRC Screening
NCT number
NCT05714644
Status
Completed
Phases
Not applicable
Enrollment
5,127 participants, actual
Lead sponsor
Massachusetts General Hospital
Conditions
Colorectal Cancer
Interventions
FIT kit Screening Test, Cologuard Screening Test
First posted
2023-02-06
Last updated
2025-12-26
Results first posted
2025-12-26
Limitations and caveats
Boston and LA used different FIT kit brands. No access to patient-level data about outreach attempts or contacts from the Exact Science patient support program because this information is proprietary.~Unable to comment on cost-effectiveness. Unable to randomize the South Dakota site because unable to identify another CHC in the region to participate.

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryCRC Screening Completion Rates3 monthscompletion rate of the stool-based screening test (FIT or Cologuard)
SecondaryCRC Screening Completion Rates6 monthscompletion rate of the stool-based screening test (Cologuard or FIT)
SecondaryDiagnostic Colonoscopy Completion Rates6 monthscompletion rate of diagnostic colonoscopy after an abnormal stool test result (overall and by arm)

Outcomes3

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYCRC Screening Completion Rates3 monthsParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYCRC Screening Completion Rates6 monthsParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYDiagnostic Colonoscopy Completion Rates6 monthsThe number is for participants who returned an abnormal stool test within 180 days.ParticipantsCOUNT_OF_PARTICIPANTS

Results by group6

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
CRC Screening Completion RatesMailed FIT Kit550Participants
CRC Screening Completion RatesCologuard751Participants
CRC Screening Completion RatesMailed FIT Kit649Participants
CRC Screening Completion RatesCologuard854Participants
Diagnostic Colonoscopy Completion RatesMailed FIT Kit13Participants
Diagnostic Colonoscopy Completion RatesCologuard23Participants

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDMailed FIT Kit2,4354
Overall StudySTARTEDCologuard2,6924
Overall StudyCOMPLETEDMailed FIT Kit2,4354
Overall StudyCOMPLETEDCologuard2,6924
Overall StudyNOT COMPLETEDMailed FIT Kit00
Overall StudyNOT COMPLETEDCologuard00

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityMailed FIT Kit02,435
Total, all-cause mortalityCologuard02,692
Total, other adverse eventsMailed FIT Kit02,435
Total, other adverse eventsCologuard02,692
Total, serious adverse eventsMailed FIT Kit02,435
Total, serious adverse eventsCologuard02,692

Papers2

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
39068985BACKGROUNDPubMed
42043827DERIVEDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons5

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Mailed FIT Kit vs Cologuard: Diagnostic Colonoscopy Completion RatesTrial comparisons
Mailed FIT Kit vs Cologuard: CRC Screening Completion RatesTrial comparisons
Mailed FIT Kit vs Cologuard: CRC Screening Completion RatesTrial comparisons
Mailed FIT Kit vs Cologuard: deaths from any causeTrial comparisons
Mailed FIT Kit vs Cologuard: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT05714644

GET https://conductscience.org/api/trials/v1/NCT05714644/registered